She underwent surgery to remove the cancerous breast but refused further medical treatment – no radiation , no chemo and no tamoxifen, etc. She opted for our therapy – i. e., herbs and change of diet. Why did she not want to go for chemo, radiotherapy, etc.? Unfortunately, Ina came...
Radiation Oncology Sarcoma Screening Skin Cancer & Melanoma Surgery Thyroid Cancer Choose Specialty May 29, 2023 Article Findings from the phase 3 DAWNA-2 trial suggest that dalpiciclib plus endocrine therapy may be a potential novel first-line treatment option for hormone receptor–positive, HER2...
Nat. Rev. Cancer 21, 345–359 (2021). Article CAS PubMed PubMed Central Google Scholar Monjazeb, A. M. et al. A randomized trial of combined PD-L1 and CTLA-4 inhibition with targeted low-dose or hypofractionated radiation for patients with metastatic colorectal cancer. Clin. Cancer Res...
Triple-negative breast cancer (TNBC) is the most malignant subtype of breast cancer (BC) with a poor prognosis. Current treatment options are limited to surgery, adjuvant chemotherapy and radiotherapy; however, a proportion of patients have missed the surgical window at the time of diagnosis. TNBC...
It was like I saw another way to perform where stages are set in the cancer space at hotels and convention centers instead of Broadway. One would think I am insecure now, mainly because of the massive weight gain due to the collateral damage from chemo, multiple surgeries, radiation, ...
So since then and much more intensely recently, I’ve been worried about this little 7mm sucker that is in my body, potentitally cancerous. Of course, in the theory the chemo should kill it, as should the extra radiation I’m having to this particular area in doses equivilent to ...
shedding light on potential targets for therapeutic intervention. Notably, emerging evidence suggests a critical role for heme oxygenases, particularly HO-1, in breast cancer progression and therapeutic resistance, highlighting the importance of understanding heme metabolism in cancer biology. Furthermore, ...
TargetMol's Anti-Breast Cancer Compound Library collects 2440 compounds related to breast cancer, including all reported compounds with anti-breast cancer therapeutic effect, and compounds targeting related targets in signaling pathway (HER-2, VEGF, EGFR, PARP, CDK4/6, HSP, PD-1, SET7/9, BRCA...
Here, we conduct a phosphoproteomic screening of samples from HER2-negative female breast cancer receiving neoadjuvant paclitaxel (N = 130), aiming to find candidate biomarkers of paclitaxel sensitivity. Filtering 11 candidate biomarkers through 2 independent patient sets (N = 218) allowed ...
Triple-negative breast cancer (TNBC) is highly aggressive, difficult to treat and commonly develops visceral metastasis, including lung metastasis. We observed that High mobility group box 1 protein (HMGB1) was highly expressed in human TNBC and positive